Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032)

Clinical trial NCT02092285 · COMPLETED

Trial details

NCT number: NCT02092285
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2014-05-09
Primary completion: 2016-05-25
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.